Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany

Infection

Volumn 30, Issue 6, 2002, Pages 351-355

  Schlipkoter U ^a   Muhlberger N ^a   Von Kries, Ruediger ^a   Weil, John ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b GSK   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; ASEPTIC MENINGITIS; ATAXIA; CLINICAL ARTICLE; DIARRHEA; DROWSINESS; DRUG DOSE; FEVER; GAIT DISORDER; GASTROENTERITIS; GERMANY; HEADACHE; HEART PALPITATION; HUMAN; OPSOCLONUS; PUBLIC HEALTH; RHINORRHEA; RIGIDITY; SEIZURE; VACCINATION; VOMITING;

CHILD; CHILD, PRESCHOOL; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; MENINGITIS, ASEPTIC;

EID: 0036448532     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-3027-8     Document Type: Article

References (18)

1. Robert-Koch Institut: Impfempfehlungen der ständigen impfkommision (STIKO) am Robert-Koch-Institut/stand April 1998. Epid Bull 15/98.
2. Robert-Koch Institut: Impfempfehlungen der ständigen impfkommision (STIKO) am Robert-Koch-Institut/stand Januar 2000. Epid Bull 2/2000.
3. Robert-Koch Institut: Impfempfehlungen der ständigen impfkommision (STIKO) am Robert-Koch-Institut/stand Juli 2001. Epid Bull 2001; 28: 203-218.
4. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L, Tettmar R: Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet 1993; 341: 979-982.
5. Brown EG, Furesz J, Dimcock K, Yarosh W, Contreras G: Nucleotide sequence analysis of Urabe mumps strain that caused meningitis in vaccine recipients. Vaccine 1991; 9: 840-842.
6. Yawata M: Japan's troubles with measles-mumps-rubella vaccine (commentary) Lancet 1994; 343: 105-106.
7. Cizman M, Mozetic M, Radescek-Raka R, Pleterski-Rigler D, Susec-Michieli M: Meningitis after vaccination against measles and mumps. Infect Dis J 1989; 8: 302-308.
8. Tesovic-G, Begovac-J, Bace-A: Asceptic meningitis after measles, mumps and vaccine. Lancet 1993; 341 (8859): 1541.
9. Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E: A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345: 567-569.
10. Schmitt H-J, Just M, Neiss A: Withdrawal of a mumps vaccine: Reasons and impacts. Eur J Pediatr 1993; 152: 384-388.
11. Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R: Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr Infect Dis J 1999; 18: 42-48.
12. Forsey T, Minor PD: Mumps viruses and mumps, measles and rubella vaccine. BMJ 1989; 2: 1340.
13. Balraj V, Miller E: Complications of mumps vaccines. Rev Med Virol 1995; 5: 219-227.
14. Plesner AM, Hansen FJ, Taudorf K, Nielsen LH, Larsen CB, Pedersen E: Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: A follow-up study. Acta Paediatr 2000; 89: 58-63.
15. Hanley JA, Lippman-Hand A: If nothing goes wrong, is everything all right?, JAMA 1983; 249: 1743-1745.
16. Eypasch E, Lefering R, Kum CK, Troidl H: Probability of adverse events that have not yet occurred: A statistical reminder. BMJ 1995; 311: 619-620.
17. Chen RT, Glasser JW, Rhodes PH, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC, Swint E, Hardy JR, Payne T, Benson P, Draket J, Drew L, Mendius B, Ray P, Lewis N, Fireman BH, Jing J, Wulfsohn M, Lugg MM, Osborne P, Rastogi S, Patriarca P, Caserta V: Vaccine Safety Datalink Project: A new tool for improving vaccine safety monitoring in the United States. Pediatrics 1997; 99: 765-773.
18. Rossi AC, Bosco J, Faich GA, Tanner A, Temple R: The importance of adverse reaction reporting by physicians. JAMA 1988; 259: 1203-1204.